HDAC9 and colonic neoplasm: A roadblock to appropriately positioned neoepitopes involves epigenetic silencing of MHC components, and the ability of linoleate and butanoate metabolites to inhibit HDAC activity and to re–express MHC functional complexes at the surface of colon cancer cells is worthy of further investigation.